Reuters logo
BRIEF-Abbott gets FDA clearance for its Alinity ci-series instruments
October 31, 2017 / 1:15 PM / a month ago

BRIEF-Abbott gets FDA clearance for its Alinity ci-series instruments

Oct 31 (Reuters) - Abbott Laboratories

* Abbott announces FDA clearance for its Alinity ci-series next-generation diagnostic systems

* Abbott laboratories - ‍secured U.S. FDA 510(k) clearance for its alinity ci-series instruments for clinical chemistry and immunoassay diagnostics​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below